scispace - formally typeset
E

Ewelina Stelcer

Researcher at Poznan University of Medical Sciences

Publications -  12
Citations -  113

Ewelina Stelcer is an academic researcher from Poznan University of Medical Sciences. The author has contributed to research in topics: Regenerative medicine & DNA damage. The author has an hindex of 5, co-authored 9 publications receiving 55 citations. Previous affiliations of Ewelina Stelcer include Medical University of Warsaw.

Papers
More filters
Journal ArticleDOI

Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View.

TL;DR: The presented review of the body of evidence suggests that additional research in molecular biology may help to establish novel treatments for oligometastatic PCa, and liquid biopsies offer a rapid, non-invasive approach whose use is expected to play an important role in routine clinical practice to benefit patients.
Journal ArticleDOI

The Role of MicroRNAs in Early Chondrogenesis of Human Induced Pluripotent Stem Cells (hiPSCs).

TL;DR: The main aim of this study was to investigate the microRNA expression profile and to select microRNAs (miRNAs) taking part in early chondrogenesis, contributing to a better understanding of the role of miRNAs directly involved in chondrocyte-like cells from hiPSCs.
Journal ArticleDOI

Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line.

TL;DR: The main purpose of the present study was to investigate the effect of adropin on proliferation and secretory activity in the human HAC15 adrenal carcinoma cell line and demonstrated that expression of GPR19 is elevated in adrenocortical carcinoma in relation to normal adrenal glands.
Journal ArticleDOI

Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide

TL;DR: The ability of lichen secondary metabolites to cross the blood-brain barrier and exert cytotoxicity against GBM cells is confirmed and caperatic acid in particular should be further analyzed as potential anti-GBM agents.